shannah
Senior Member
- Messages
- 1,429
From Rick Laferriere
Utah drug research company, Curza, takes aim at Lyme disease By Chris Miller, KUTV-TV, Salt Lake City, Utah
August 25, 2015
http://kutv.com/news/local/utah-drug-research-company-curza-takes-aim-at-lyme-disease
or http://tinyurl.com/pdpatqh
Curza, a Provo-based pharmaceutical research company, is on the cusp of a medical breakthrough that could treat victims of chronic Lyme disease.
The company is entering phase two of clinical research on their newly designed antibiotic called CZ-99. They'll soon be testing the drug on infected mice at the University of California, Davis.
An initial clinical trial at the University of New Haven in Connecticut, found CZ-99 to be 60 percent more effective in treating Lyme disease than the traditional antibiotics used to treat the illness.
Curza CEO Ryan Davies says they have a patent on a technology used to penetrate bacteria's protective outer layer, or biofilm, making its new antibiotic more effective than outdated medications.
Utah drug research company, Curza, takes aim at Lyme disease By Chris Miller, KUTV-TV, Salt Lake City, Utah
August 25, 2015
http://kutv.com/news/local/utah-drug-research-company-curza-takes-aim-at-lyme-disease
or http://tinyurl.com/pdpatqh
Curza, a Provo-based pharmaceutical research company, is on the cusp of a medical breakthrough that could treat victims of chronic Lyme disease.
The company is entering phase two of clinical research on their newly designed antibiotic called CZ-99. They'll soon be testing the drug on infected mice at the University of California, Davis.
An initial clinical trial at the University of New Haven in Connecticut, found CZ-99 to be 60 percent more effective in treating Lyme disease than the traditional antibiotics used to treat the illness.
Curza CEO Ryan Davies says they have a patent on a technology used to penetrate bacteria's protective outer layer, or biofilm, making its new antibiotic more effective than outdated medications.